Pfizer expecting full FDA approval for its COVID-19 vaccine today

Pfizer Inc’s (NYSE: PFE) COVID-19 vaccine that it developed in collaboration with German BioNTech is expected to receive full FDA approval on Monday – a few weeks ahead of the announced deadline of September 6th. The drug regulatory authority refrained from commenting any further on the news first reported by the New York Times. Despite […]